OTC: GCTK · Industrial Applications and Services · 11 alerts · CIK 1506983
Share price
$0.1900Close, Nov 16
Market cap
$2.01M
Shares outstanding
10.58MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Glucotrack, Inc. filings on SEC EDGAR ↗
Glucotrack received notice from a Nasdaq Hearings Panel that its securities will be delisted after failing to maintain a $1.00 minimum bid price through the required exception period. Trading on Nasdaq will be suspended on October 30, 2026, and the company plans to transition its common stock to the OTC Markets Group (OTCID).
Glucotrack, Inc. filed an amended 8-K to provide updated pro forma financial statements regarding its completed acquisition of Lokahi Therapeutics Inc. The update specifically reflects the impact of a 1-for-15 reverse stock split that became effective on August 28, 2026. Following the merger, Lokahi became a direct wholly owned subsidiary of Glucotrack.
Glucotrack, Inc. entered into a securities purchase agreement for a registered direct offering of 169,388 shares of common stock and pre-funded warrants for 1,350,220 shares, raising approximately $3.1 million in gross proceeds. The offering was priced at $2.04 per share (or $2.039 per pre-funded warrant) and is intended to fund debt repayment and general working capital.